Stock data
Pacific Biosciences of California, Inc. (PACB)
Pacific Biosciences of California, Inc. (PACB) reported net income of -US$546.38M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | US$45.78M | -US$553.86M | -US$546.38M | — |
| 2024 | — | US$37.28M | -US$474.31M | -US$309.85M | — |
| 2023 | — | US$52.78M | -US$334.47M | -US$306.74M | — |
| 2022 | — | US$49.03M | -US$307.20M | -US$314.25M | — |
| 2021 | — | US$58.86M | -US$210.44M | -US$181.22M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$39.01M | -US$44.74M | — |
| 2026-03-31 | US$37.18M | -US$8.28M | — |
| 2025-12-31 | — | -US$40.37M | — |
| 2025-09-30 | US$38.44M | -US$38.00M | — |
| 2025-06-30 | US$39.77M | -US$41.93M | — |
| 2025-03-31 | US$37.15M | -US$426.07M | — |
| 2024-12-31 | — | US$2.37M | — |
| 2024-09-30 | US$39.97M | -US$60.73M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.